1
Disclosures
Jan 8, 2026 — Mar 25, 2026
Date Range
GROWTH
Market Segment

Disclosures

DateTypeHeadlinePDF
Mar 25 Other Delta-Fly Pharma: Reports Positive Phase 1/2 Trial Results for DFP-101 Combined With Venetoclax PDF

Disclosure Types

Other: 1